Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 01, 2008. The report serves as a notification to the market regarding the Company's issued share capital and total voting rights as of November 30, 2008, in conformity with Disclosure and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a capital structure notification and contains no financial performance data.
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. It solely reports the current status of share capital and voting rights.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to statutory disclosure of share counts.
Important Facts for Investors
- Issued Share Capital: As of November 30, 2008, the Company had 5,676,276,259 Ordinary shares of 25p each.
- Treasury Shares: 474,194,158 Ordinary shares are held in Treasury.
- Total Voting Rights: The total number of voting rights is 5,202,082,101.
- Regulatory Use: This figure serves as the denominator for shareholders calculating notification requirements under the Financial Services Authority's Disclosure and Transparency Rules.